Natural Health Trends Corp.
|
||
(Exact Name of Registrant as Specified in Its Charter)
|
||
Delaware | ||
(State or Other Jurisdiction of Incorporation)
|
||
0-26272 | 59-2705336 | |
(Commission File Number) | (IRS Employer Identification No.) | |
4514 Cole Avenue, Suite 1400, Dallas, Texas | 75205 | |
(Address of Principal Executive Offices) | (Zip Code) | |
(972) 241-4080
|
||
(Registrant’s Telephone Number, Including Area Code)
|
(a)
|
Financial statements:
|
(b)
|
Pro forma financial information:
|
(c)
|
Shell company transactions:
|
(d)
|
Exhibits
|
NATURAL HEALTH TRENDS CORP.
|
|||
Date: November 13, 2012
|
By:
|
/s/ Gary C. Wallace | |
Gary C. Wallace
General Counsel
|
|||
Company Contact
|
Investor Contact
|
Scott Davidson
|
Brett Maas
|
Chief Financial Officer
|
Managing Partner
|
Natural Health Trends Corp.
|
Hayden IR
|
Tel: 972-241-4080
|
Tel: 646-536-7331
|
scott.davidson@nthglobal.com
|
brett@haydenir.com
|
·
|
Total revenues were $9.3 million compared to $10.6 million for the same period in 2011, a decrease of 11.6%. The decrease in revenues for the third quarter reflects the promotional event during 2011 related to the Company’s 10-year anniversary celebration in Hong Kong, which did not benefit 2012.
|
|
o
|
Sales in Hong Kong decreased 20.5% compared to last year, primarily due to last year’s major promotion.
|
|
o
|
Net sales outside of Hong Kong increased 23.9%, primarily due to sales in the Russian market.
|
·
|
Gross profit was $6.9 million compared to $8.0 million last year.
|
·
|
Gross profit margin was 74.5% compared to 76.0% last year.
|
·
|
Operating income was $789,000 compared to $1.2 million last year.
|
·
|
Net income attributable to common stockholders of Natural Health Trends was $743,000, or $0.07 per basic and diluted share, compared to net income of $1.6 million, or $0.15 per basic and diluted share last year.
|
·
|
Cash and cash equivalents increased to $3.7 million as of September 31, 2012 from $1.6 million as of December 31, 2011.
|
·
|
Net sales for the nine months ended September 30, 2012 were up $6.5 million, or 28.1%, to $29. 4 million from $22.9 million in the same period last year. Year-to-date (nine month) revenues are 94.4% of the full-year (12 month) revenue from the year ended December 31, 2011.
|
|
o
|
Sales in Hong Kong increased 35.3% compared to the prior-year nine month period.
|
|
o
|
Net sales outside of Hong Kong increased 13.3%, primarily due to sales in the Russian market.
|
·
|
Year-to-date gross profit increased 28.6% to $21.7 million from $16.9 million in the same period last year.
|
·
|
Year-to-date gross profit margin was 73.9% compared to 73.7% in the first nine months of last year.
|
·
|
Year-to-date operating income increased 48.5% to $2.2 million from $1.5 million in the same period last year. Nine month operating income this year exceeds 12 month operating income of $1.8 million for all of last year.
|
·
|
Year-to-date net income attributable to common stockholders of Natural Health Trends increased 14.9% to $2.1 million from $1.8 million in the same period last year.
|
·
|
The Company continued to evolve and enhance its technology platform integrating a unique loyalty program called the Personal Consumption Program. Members earn points for product purchases, attending trainings and events and reaching business milestones. These accumulated points can be used toward future product purchases or for gifting to team members.
|
·
|
The Company introduced a new product, HerBalance, in July and readies another, Soothe, for Hong Kong and Russia in the fourth quarter. HerBalance is a daily supplement to help alleviate women’s pre- and post-menopausal symptoms while supporting healthier blood circulation. Soothe is an all-over super hydrating body moisturizer ideal for extreme weather conditions.
|
·
|
The Company continued to roll out its systemic training initiatives in Hong Kong, Taiwan and Russia. These multi-faceted trainings support enhanced product knowledge, business fundamentals for success and leadership training.
|
·
|
Incentive trips brought our members to Hawaii, Dubai and Las Vegas, among other locations just this year.
|
|
·
|
Date: Tuesday, November 13, 2012
|
|
·
|
Time: 4:30 p.m. ET/3:30 p.m. CT
|
|
·
|
Dial-in number: 1-877-941-1427 (domestic) 1-480-629-9664 (international)
|
|
·
|
Webcast link: http://public.viavid.com/index.php?id=102347
|
December 31,
2011
|
September 30,
2012
|
|||||||
(Unaudited)
|
||||||||
ASSETS
|
||||||||
Current assets:
|
||||||||
Cash and cash equivalents
|
$ | 1,617 | $ | 3,651 | ||||
Restricted cash
|
494 | – | ||||||
Accounts receivable
|
93 | 166 | ||||||
Inventories, net
|
1,089 | 1,261 | ||||||
Other current assets
|
537 | 446 | ||||||
Total current assets
|
3,830 | 5,524 | ||||||
Property and equipment, net
|
68 | 129 | ||||||
Goodwill
|
1,764 | 1,764 | ||||||
Restricted cash
|
220 | 231 | ||||||
Other assets
|
241 | 252 | ||||||
Total assets
|
$ | 6,123 | $ | 7,900 | ||||
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
|
||||||||
Current liabilities:
|
||||||||
Accounts payable
|
$ | 2,208 | $ | 1,795 | ||||
Income taxes payable
|
11 | 79 | ||||||
Accrued distributor commissions
|
1,177 | 1,293 | ||||||
Other accrued expenses
|
1,471 | 1,531 | ||||||
Deferred revenue
|
967 | 768 | ||||||
Deferred tax liability
|
148 | 148 | ||||||
Other current liabilities
|
950 | 896 | ||||||
Total current liabilities
|
6,932 | 6,510 | ||||||
Commitments and contingencies
|
||||||||
Stockholders’ equity (deficit):
|
||||||||
Preferred stock, $0.001 par value; 5,000,000 shares authorized; 1,761,900 shares designated Series A convertible preferred stock, 138,400 shares issued and outstanding at December 31, 2011 and September 30, 2012, aggregate liquidation value of $324
|
124 | 124 | ||||||
Common stock, $0.001 par value; 50,000,000 shares authorized; 11,326,323 shares issued and outstanding at December 31, 2011 and September 30, 2012
|
11 | 11 | ||||||
Additional paid-in capital
|
80,493 | 80,553 | ||||||
Accumulated deficit
|
(81,338 | ) | (79,238 | ) | ||||
Accumulated other comprehensive loss:
|
||||||||
Foreign currency translation adjustments
|
(99 | ) | (60 | ) | ||||
Total stockholders’ equity (deficit)
|
(809 | ) | 1,390 | |||||
Total liabilities and stockholders’ equity (deficit)
|
$ | 6,123 | $ | 7,900 |
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
2011
|
2012
|
2011
|
2012
|
|||||||||||||
Net sales
|
$ | 10,562 | $ | 9,333 | $ | 22,945 | $ | 29,403 | ||||||||
Cost of sales
|
2,536 | 2,384 | 6,042 | 7,667 | ||||||||||||
Gross profit
|
8,026 | 6,949 | 16,903 | 21,736 | ||||||||||||
Operating expenses:
|
||||||||||||||||
Distributor commissions
|
4,166 | 3,897 | 8,642 | 12,474 | ||||||||||||
Selling, general and administrative expenses (including stock-based compensation expense of $22 and $20 during the three months ended September 30, 2011 and 2012, respectively, and $57 and $60 during the nine months ended September 30, 2011 and 2012, respectively)
|
2,613 | 2,255 | 6,479 | 7,005 | ||||||||||||
Depreciation and amortization
|
23 | 8 | 281 | 28 | ||||||||||||
Total operating expenses
|
6,802 | 6,160 | 15,402 | 19,507 | ||||||||||||
Income from operations
|
1,224 | 789 | 1,501 | 2,229 | ||||||||||||
Other income (expense), net
|
425 | (27 | ) | 356 | (88 | ) | ||||||||||
Income before income taxes
|
1,649 | 762 | 1,857 | 2,141 | ||||||||||||
Income tax provision
|
16 | 15 | 36 | 41 | ||||||||||||
Net income
|
1,633 | 747 | 1,821 | 2,100 | ||||||||||||
Plus: Net loss attributable to the noncontrolling interest
|
– | – | 9 | – | ||||||||||||
Net income attributable to Natural Health Trends
|
1,633 | 747 | 1,830 | 2,100 | ||||||||||||
Preferred stock dividends
|
(4 | ) | (4 | ) | (12 | ) | (12 | ) | ||||||||
Net income attributable to common stockholders of Natural Health Trends
|
$ | 1,629 | $ | 743 | $ | 1,818 | $ | 2,088 | ||||||||
Income per share of Natural Health Trends – basic and diluted
|
$ | 0.15 | $ | 0.07 | $ | 0.17 | $ | 0.19 | ||||||||
Weighted-average number of shares outstanding:
|
||||||||||||||||
Basic
|
10,732 | 10,970 | 10,669 | 10,918 | ||||||||||||
Diluted
|
10,898 | 11,232 | 10,699 | 11,225 |
Nine Months Ended
September 30,
|
||||||||
2011
|
2012
|
|||||||
CASH FLOWS FROM OPERATING ACTIVITIES:
|
||||||||
Net income
|
$ | 1,821 | $ | 2,100 | ||||
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||
Depreciation and amortization of property and equipment
|
81 | 28 | ||||||
Amortization of intangibles
|
200 | – | ||||||
Stock-based compensation
|
57 | 60 | ||||||
Deferred income taxes
|
(1 | ) | – | |||||
Changes in assets and liabilities:
|
||||||||
Accounts receivable
|
12 | (69 | ) | |||||
Inventories, net
|
(362 | ) | (163 | ) | ||||
Other current assets
|
72 | 93 | ||||||
Other assets
|
170 | (4 | ) | |||||
Accounts payable
|
(661 | ) | (416 | ) | ||||
Income taxes payable
|
(15 | ) | 68 | |||||
Accrued distributor commissions
|
318 | 108 | ||||||
Other accrued expenses
|
(706 | ) | 51 | |||||
Deferred revenue
|
418 | (205 | ) | |||||
Other current liabilities
|
33 | (56 | ) | |||||
Net cash provided by operating activities
|
1,437 | 1,595 | ||||||
CASH FLOWS FROM INVESTING ACTIVITIES:
|
||||||||
Purchases of property and equipment, net
|
(7 | ) | (88 | ) | ||||
Decrease (increase) in restricted cash
|
(72 | ) | 493 | |||||
Net cash provided by (used in) investing activities
|
(79 | ) | 405 | |||||
CASH FLOWS FROM FINANCING ACTIVITIES
|
||||||||
Advance from related party
|
233 | – | ||||||
Repayment to related party
|
(114 | ) | – | |||||
Net cash provided by financing activities
|
119 | – | ||||||
|
||||||||
Effect of exchange rates on cash and cash equivalents
|
(398 | ) | 34 | |||||
Net increase in cash and cash equivalents
|
1,079 | 2,034 | ||||||
CASH AND CASH EQUIVALENTS, beginning of period
|
648 | 1,617 | ||||||
CASH AND CASH EQUIVALENTS, end of period
|
$ | 1,727 | $ | 3,651 |